FFS
DARE icon

Founders Financial Securities’s Dare Bioscience DARE Stock Holding History

Founders Financial Securities’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,586
Closed -$37.5K – 439
2024
Q3 		$37.5K Buy
+11,586
New +$39.6K ﹤0.01% 418
2024
Q2 		– Sell
-10,333
Closed -$60.8K – 427
2024
Q1 		$60.8K Hold
10,333
– – 0.01% 376
2023
Q4 		$38.3K Hold
10,333
– – ﹤0.01% 360
2023
Q3 		$57.3K Buy
10,333
+833
+9% +$6.85K 0.01% 320
2023
Q2 		$104K Hold
9,500
– – 0.01% 310
2023
Q1 		$119K Hold
9,500
– – 0.02% 307
2022
Q4 		$94.6K Sell
9,500
-19,485
-67% -$218K 0.01% 312
2022
Q3 		$5.27M Buy
28,985
+20,360
+236% +$280K 0.93% 20
2022
Q2 		$127K Buy
+8,625
New +$130K 0.02% 251
2022
Q1 		– Sell
-8,625
Closed -$207K – 262
2021
Q4 		$207K Buy
8,625
+417
+5% +$8.58K 0.04% 248
2021
Q3 		$164K Hold
8,208
– – 0.03% 248
2021
Q2 		$186K Buy
8,208
+4,041
+97% +$69.1K 0.04% 285
2021
Q1 		$84K Hold
4,167
– – 0.02% 254
2020
Q4 		$67K Hold
4,167
– – 0.02% 225
2020
Q3 		$50K Sell
4,167
-3,958
-49% -$52.8K 0.02% 157
2020
Q2 		$102K Buy
8,125
+6,458
+387% +$79.1K 0.03% 167
2020
Q1 		$17K Buy
+1,667
New +$22.4K 0.01% 126
2019
Q4 		– Sell
-1,667
Closed -$16K – 125
2019
Q3 		$16K Hold
1,667
– – 0.01% 131
2019
Q2 		$17K Buy
+1,667
New +$19.8K 0.01% 114

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Founders Financial Securities's DARE Position: Q4 2024 in Review

Founders Financial Securities sold out of Dare Bioscience (DARE) in Q4 2024, closing a stake of 11,586 shares — an estimated $37.5K sold.

Founders Financial Securities first reported a position in DARE in Q2 2019 and held it in 19 quarters. The position peaked at $5.27M in Q3 2022. 25 funds tracked by Wall St. Rank hold DARE as of Q4 2024.

  • Founders Financial Securities reported no remaining Dare Bioscience position as of Q4 2024 after selling out during the quarter.
  • Founders Financial Securities sold 11,586 Dare Bioscience shares in Q4 2024, an estimated $37.5K.
  • Founders Financial Securities first reported a position in Dare Bioscience in Q2 2019 and held it in 19 quarters.
  • Founders Financial Securities's Dare Bioscience position peaked at $5.27M in Q3 2022.
  • 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q4 2024.

Based on Founders Financial Securities's 13F filing for Q4 2024, filed 10 Feb 2025.